Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Squamous cell lung cancer: Current landscape and future therapeutic options
Sally C. M. Lau, Yuanwang Pan, Vamsidhar Velcheti, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1279-1293
Open Access | Times Cited: 91

Showing 26-50 of 91 citing articles:

USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
Juntae Kwon, Jinmin Zhang, Boram Mok, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma
Xiang Zhang, Qingqing Xiao, Cong Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 3
Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
David Kozono, Xing Hua, Michael C. Wu, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 12, pp. 1618-1629
Closed Access | Times Cited: 3
Landscape of targeted therapies for lung squamous cell carcinoma
Qiuxuan Chen, Xiao-Shuo Zheng, Weiting Cheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Successful treatment of immune-related lichenoid dermatitis by Weiling decoction in a patient with non-small cell lung cancer: A case report and review of literature
Ying Liu, Jiong Tang, Lin-Yuan Yu, et al.
EXPLORE (2023) Vol. 19, Iss. 5, pp. 730-735
Closed Access | Times Cited: 7
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma – morphology, molecular characteristics and differential diagnosis
Sabina Berezowska, Marie Maillard, Mark Keyter, et al.
Histopathology (2023) Vol. 84, Iss. 1, pp. 32-49
Open Access | Times Cited: 7
Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology
Martin Zacharias, Selma Konjić, Nikolaus Kratochwill, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 903-903
Open Access | Times Cited: 2
TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
Triet Nguyen, Francesca A. Carrieri, Nick Connis, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 8, pp. 1201-1211
Open Access | Times Cited: 2
Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma
Li Guo, Chen Lü, Hua Bai, et al.
Precision Clinical Medicine (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 2
Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance
M. A. Senchukova, E. A. Kalinin, Nadezhda N Volchenko
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 5, pp. 614-634
Open Access | Times Cited: 2
p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications
Dixan A. Benitez, Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 2
Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma
Jinzhi Lai, Xinyi Lin, Huangna Zheng, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma
Longjin Zeng, Lingchen Li, Xingyun Liao, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Open Access | Times Cited: 1
MiR-320a upregulation contributes to the effectiveness of pemetrexed by inhibiting the growth and invasion of human lung cancer cell line (Calu-6)
Akbar Ghorbani Alvanegh, Ayyoob Arpanaei, Hadi Esmaeili Gouvarchin Ghaleh, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
A novel gene signature related to fatty acid metabolism predicts prognosis, immune landscape, and drug sensitivity in early-stage lung squamous cell carcinoma
Juqing Xu, Maoran Yu, Weifei Fan, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 525-541
Open Access | Times Cited: 1
High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers
Sook Hee Hong, Tae‐Min Kim
Translational Lung Cancer Research (2024) Vol. 13, Iss. 2, pp. 236-239
Open Access | Times Cited: 1
A novel prognostic signature of coagulation-related genes leveraged by machine learning algorithms for lung squamous cell carcinoma
Guosheng Li, Rong‐Quan He, Zhi‐Guang Huang, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27595-e27595
Open Access | Times Cited: 1
Bulk and single-cell RNA sequencing reveal the contribution of laminin γ2 -CD44 to the immune resistance in lymphocyte-infiltrated squamous lung cancer subtype
Tingting Song, Ying Yang, Yilong Wang, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31299-e31299
Open Access | Times Cited: 1
Toll-like Receptors: Key Players in Squamous Cell Carcinoma Progression
Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4531-4531
Open Access | Times Cited: 1
Unveiling potential drug targets for lung squamous cell carcinoma through the integration of druggable genome and genome-wide association data
Wenhua Wu, Zhengrui Chen, Haiteng Wen, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Revolutionizing Lung Cancer Treatment with Smart Pulmonary Drug Delivery Nanosystems
Osman Gamal, Abdullah T. Agamey, Zeinab A. Mohamed, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106158-106158
Closed Access | Times Cited: 1
Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1
Qi Li, Wenjie Yang, Qingyi Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
IGF2BP3/CTCF Axis–Dependent NT5DC2 Promotes M2 Macrophage Polarization to Enhance the Malignant Progression of Lung Squamous Cell Carcinomas
Jifeng Sun, Hao Wang, Ran Zhang, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 11
Open Access | Times Cited: 1
Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches
Maryam Dokhanchi, Atefe Panahipoor Javaherdehi, Mohammad Raad, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
Mechanistic Insights of hsa-mir-301a Regulation by Tobacco Smoke in Lung Squamous Cell Carcinoma: Evidence From Bioinformatics Analysis
Vladimir O. Pustylnyak, Alina M. Perevalova, L. F. Gulyaeva
Bioinformatics and Biology Insights (2024) Vol. 18
Open Access | Times Cited: 1

Scroll to top